Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 1,330 · FY2023 0 · FY2024 3,000 — 3-yr total 4,330
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2024 annual report, the company provides general medical practice and healthcare services to individuals and families. Founded in 2007; began active operations in 2012. 50-50% ownership between two LLC partners.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 96.1% | 94.7% | 95.4% | 95.4% | 94.3% | 94.2% | 93.1% | 93.4% |
| EBITDA Margin | 88.8% | 29.5% | 34.6% | 43.6% | 40.6% | 35.2% | 15.8% | 30.4% |
| EBITDAR | 6,565 | 1,943 | 2,233 | 2,814 | 3,510 | 2,897 | 1,130 | 2,934 |
| EBITDAR Margin | 88.8% | 29.5% | 34.6% | 43.6% | 40.6% | 35.2% | 15.8% | 30.4% |
| EBIT Margin | 83.3% | 23.0% | 27.7% | 34.7% | 33.4% | 27.6% | 7.1% | 20.8% |
| Net Profit Margin | 38.2% | 23.0% | 27.7% | 34.7% | 33.4% | 28.7% | 9.8% | 21.4% |
| Operating Expense % of Sales | 7.3% | 65.2% | 60.8% | 51.8% | 53.7% | 58.9% | 77.3% | 63.0% |
| Returns | ||||||||
| Return on Assets (ROA) | 24.5% | 13.3% | 13.4% | 15.9% | 20.1% | 15.3% | 4.0% | 12.0% |
| Return on Equity (ROE) | 25.4% | 13.9% | 14.2% | 16.4% | 20.8% | 15.8% | 4.5% | 14.1% |
| ROIC [EBIT / Invested Capital] | 65.6% | 14.3% | 14.7% | 17.1% | 22.6% | 17.6% | 4.2% | 13.7% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 96.6% | 95.3% | 94.8% | 97.3% | 96.4% | 96.7% | 88.4% | 85.2% |
| Net Debt | -1,736 | -243 | -436 | -607 | -1,082 | -1,986 | -3,330 | -24 |
| Cash & Equivalents | 1,736 | 243 | 436 | 607 | 1,082 | 1,986 | 3,330 | 24 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||||||
| Current Ratio | 8.03x | 2.42x | 2.09x | 4.73x | 4.73x | 5.89x | 2.34x | 0.49x |
| Quick Ratio | 7.90x | 2.33x | 2.02x | 4.57x | 4.61x | 5.72x | 2.29x | 0.45x |
| Cash Ratio | 4.48x | 0.45x | 0.63x | 1.61x | 2.10x | 3.95x | 1.62x | 0.01x |
| Total Current Assets | 3,111 | 1,302 | 1,439 | 1,780 | 2,433 | 2,959 | 4,796 | 1,252 |
| Total Current Liabilities | 387 | 538 | 689 | 377 | 514 | 503 | 2,053 | 2,544 |
| Inventory | 53 | 52 | 50 | 60 | 59 | 82 | 96 | 104 |
| Trade Receivables | 1,323 | 1,007 | 953 | 1,114 | 1,292 | 891 | 1,370 | 1,124 |
| Trade Payables | 387 | 538 | 689 | 377 | 514 | 503 | 2,053 | 2,544 |
| Net Working Capital | 2,724 | 764 | 750 | 1,404 | 1,918 | 2,456 | 2,743 | -1,292 |
| Net Working Capital % of Revenue | 36.8% | 11.6% | 11.6% | 21.8% | 22.2% | 29.9% | 38.4% | -13.4% |
| Trade Working Capital | 988 | 521 | 314 | 797 | 836 | 470 | -587 | -1,316 |
| Trade Working Capital % of Revenue | 13.4% | 7.9% | 4.9% | 12.4% | 9.7% | 5.7% | -8.2% | -13.7% |
| Change in Trade Working Capital | N/A | -467 | -207 | 483 | 40 | -366 | -1,057 | -729 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | 5.50x | 6.75x | 5.97x | 4.98x | 8.32x | 5.86x | 5.10x | 6.12x |
| Days Inventory Outstanding (DIO) | 66.3 | 54.1 | 61.1 | 73.4 | 43.9 | 62.3 | 71.5 | 59.6 |
| Receivables Turnover | 5.59x | 6.53x | 6.77x | 5.79x | 6.70x | 9.24x | 5.21x | 8.58x |
| Days Sales Outstanding (DSO) | 65.3 | 55.9 | 53.9 | 63.0 | 54.5 | 39.5 | 70.0 | 42.5 |
| Payables Turnover | 0.75x | 0.65x | 0.43x | 0.79x | 0.96x | 0.96x | 0.24x | 0.25x |
| Days Payable Outstanding (DPO) | 488.2 | 563.9 | 848.4 | 463.8 | 380.1 | 381.6 | 1524.6 | 1464.6 |
| Cash Conversion Cycle | -356.5 days | -454.0 days | -733.4 days | -327.4 days | -281.7 days | -279.8 days | -1383.1 days | -1362.4 days |
| Asset Turnover | 0.64x | 0.58x | 0.48x | 0.46x | 0.60x | 0.53x | 0.40x | 0.56x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 2,776 | 2,303 | 2,212 | 2,458 | 3,407 | 3,314 | 2,158 | 3,605 |
| Free Cash Flow (OCF − Capex proxy) | 2,776 | 307 | 193 | 1,371 | 3,175 | 2,234 | 1,344 | -306 |
| Cash Conversion (OCF / EBITDA) | 42.3% | 118.5% | 99.1% | 87.3% | 97.1% | 114.4% | 190.9% | 122.9% |
| Dividends Declared | 0 | 1,800 | 0 | 1,200 | 2,700 | 1,330 | 0 | 3,000 |
| Dividend Payout Ratio | 0.0% | 119.0% | 0.0% | 53.6% | 93.4% | 56.4% | 0.0% | 145.4% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →